NCT06234709 is a clinical trial in Critical Care, sponsored by Anna Aronsson.

Who is sponsoring NCT06234709?

NCT06234709 is sponsored by Anna Aronsson.

What condition does NCT06234709 study?

NCT06234709 studies Critical Care.

Is NCT06234709 still recruiting?

NCT06234709 is currently completed. Last updated 2 February 2024.

Last reviewed 2024-02-02 · How we verify

NCT06234709

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-term Mortality After Intensive Care Considering Comorbidity and Admission Diagnoses

Completed Last updated 2 February 2024

What this trial tests

trial in Critical Care in 200,000 participants. Completed in 31 December 2016.

Timeline

1 January 2005

Primary endpoint
31 December 2016

31 December 2016

Quick facts

Lead sponsor	Anna Aronsson
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200,000
Start date	1 January 2005
Primary completion	31 December 2016
Estimated completion	31 December 2016
Sites	1 location across Sweden

Conditions studied

Critical Care — all drugs for Critical Care →

Sponsor

Anna Aronsson

Who can join

16 and older, any sex, with Critical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a register-based study The aim of this study is to investigate how common comorbidity is in different age groups and which comorbidity that has the greatest impact on mortality considering different admission diagnosis and after the acute phase compared to the general population. Also, how different degrees of comorbidity affect mortality, adjusted for other comorbidities and SAPS 3?

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The long-term conditional mortality rate in older ICU patients compared to the general population.
Aronsson Dannewitz A, Svennblad B, Michaëlsson K, Lipcsey M, et al · · 2024 · cited 3× · PMID 39543756 · DOI 10.1186/s13054-024-05147-z

Verify or expand the search:

Other recruiting trials for Critical Care

Currently open trials in the same condition.

NCT06526598 — Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial · NA · recruiting
NCT06457555 — Knowledge Levels and Experiences of Intensive Care Nurses on the Prevention of Pressure Sores: Mixed Method · active not recruiting
NCT06970990 — Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments · NA · recruiting
NCT06816706 — Comparison of Physiological Effects of Two High-Flow Tracheal Oxygen Versus T-Piece During Spontaneous Breathing Trials · NA · recruiting
NCT06862700 — Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06234709 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anna Aronsson
Last refreshed: 2 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06234709.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing